Evidence map›Paper›PMID 41255983›Full record

ArticleResearch square2025

Mutant MAPT Induces rDNA Transcriptional Hyperactivation and Nucleolar Stress in Cellular Models.

Zaid Muhammad, Yan Gu, Suleiman H Kwairanga, Laura J Bailey, Amna Khan, Mohammad Nasser, Dana Aljarrah, Charles Arber, Selina Wray, Louise C Serpell and 2 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zaid MuhammadSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
Yan GuBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Suleiman H KwairangaSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
Laura J BaileyFaculty of Medical and Health Science, Newgate University Minna, Nigeria.ORCID 0000-0001-5310-2295
Amna KhanBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Mohammad NasserBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Dana AljarrahBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Charles ArberDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-9743-8134
Selina WrayDepartment of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0003-3062-7050
Louise C SerpellBiomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria.
Celeste M KarchDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-6854-5547
Mahmoud B MainaSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.ORCID 0000-0002-7421-3813

Funding

Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7M
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal ProteasesU54NS123985 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KARCH, CELESTE MARIE · 2021 to 2025
$9.0M
NIA NIH HHS P30 AG066444NINDS NIH HHS U54 NS123985Wellcome Trust
6 · The paper itself

Abstract

Tau is traditionally known for its role in microtubule stabilization, with its pathological aggregation central to tauopathies such as Alzheimer's disease (AD) and frontotemporal dementia (FTD). Recent evidence suggests that tau also plays important nuclear and nucleolar roles, yet the implications of tau pathology on nucleolar function remain poorly understood. Here, we show that tau localises to the nucleolus in both differentiated SH-SY5Y cells and iPSC-derived neurons, and accumulates upon expression of disease-associated MAPT mutations (P301S, S305N, and IVS 10 + 16). Using high-content imaging, we demonstrate that mutant tau expression leads to structural expansion of the nucleus and nucleolus, with upregulation of key markers from all three nucleolar sub-compartments, indicating increased in nucleolar activity. qPCR and nucleolar RNA-selective dye staining confirmed increased rDNA transcription and rRNA processing, suggesting that mutant tau drives elevated nucleolar biosynthetic output. This hyperactivation is accompanied by hallmarks of nucleolar stress and apoptosis, including p53 stabilisation, caspase 3/7 activation, and TUNEL positivity. These findings identify nucleolar dysfunction as a downstream consequence of mutant tau expression and highlight disruption of nucleolar homeostasis as a potential contributor to tau-mediated neurotoxicity in MAPT-linked FTD.

Identifiers

PMID41255983
PMCPMC12622150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.